The role of p21-activated kinase in the initiation of atherosclerosis by unknown
Jhaveri et al. BMC Cardiovascular Disorders 2012, 12:55
http://www.biomedcentral.com/1471-2261/12/55RESEARCH ARTICLE Open AccessThe role of p21-activated kinase in the initiation
of atherosclerosis
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Background: p21-activated kinase (PAK) has been implicated in the inflammatory activation of endothelial cells by
disturbed fluid shear stress, which is the initiating stimulus in atherosclerosis. The study addresses whether PAK1
contributes to inflammatory marker expression in endothelial cells at atherosclerosis-susceptible regions of
arteries in vivo.
Method: Aortas from WT and PAK1-/- C57BL/6J mice on a normal chow diet were fixed, dissected and processed
for immunohistochemistry using a panel of inflammatory markers. We visualized and quantified staining in the
endothelium at the greater and lesser curvatures of the arch of aorta, as atherosclerosis-resistant and susceptible
regions, respectively.
Results: Fibronectin, VCAM-1 and the activated RelA NF-κB subunit were localized to the lesser curvature and
decreased in PAK1-/- mice. The activated RelB NF-κB subunit was also localized to the lesser curvature but was
increased in PAK1-/- mice. Low levels of staining for ICAM-1 and the monocyte/macrophage marker Mac2 indicated
that overall inflammation in this tissue was minimal.
Conclusion: These data show that PAK1 has a significant pro-inflammatory function at atherosclerosis-prone sites
in vivo. These effects are seen in young mice with very low levels of inflammation, suggesting that inflammatory
activation of the endothelium is primarily biomechanical. Activation involves NF-κB, expression of leukocyte
recruitment receptors and fibronectin deposition. These results support and extend in vitro studies demonstrating
that PAK contributes to activation of inflammatory pathways in endothelial cells by fluid shear stress.
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Atherosclerosis occurs mainly at regions of vessel curva-
ture, branch points and bifurcations. These regions are
distinguished by blood flow patterns with features such
as low shear stress, flow separation and reattachment,
and flow reversal during the cardiac cycle (so-called os-
cillatory flow) [1,2]. Application of analogous flow pat-
terns to endothelial cells (ECs) in vitro recapitulates
many of the effects seen in vivo at atherosclerosis-prone
sites, including inflammatory gene expression, increased
permeability, leukocyte recruitment and cell turnover
[3–5]. In vivo, these atherosclerosis-prone regions of* Correspondence: martin.schwartz@yale.edu
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reproduction in any medium, provided the orarteries show mild chronic inflammation without plaque
formation even in WT mice or other organisms that do
not normally develop atherosclerosis [6]. Progression to
atherosclerotic plaque requires additional risk factors
such as hyperlipidemia or diabetes [2]. Taken together,
these results suggest that biomechanical activation of the
endothelium by disturbed flow is the initiating event that
determines the spatial distribution of atherosclerotic pla-
ques, whereas systemic risk factors contribute mainly to
the progression of mild inflammation into atheroscler-
osis [7,8].
p21-activated kinases (PAKs) comprise a highly con-
served family of serine/threonine protein kinases that
are important effectors of Rac and Cdc42. PAKs have
been implicated in proliferative signaling by growth fac-
tor receptor tyrosine kinases, in control of cell polarity
and actin cytoskeletal organization in higher eukaryoticLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Automated image analysis. The Image J protocol is illustrated using fibronectin staining in the lesser curvature of PAK HZ and PAK
KO mice. Minimal threshold intensity is selected such that only the endothelial cell stained regions are positive. The inner 90 pixels are isolated as
the endothelial layer. Consistent area selection across sections gives the mean integrated density in endothelial cells as a function of area and
intensity. Image J analysis cartoon of DAB stained regions (red) in the lesser curvature (LC) of PAK heterozygote (HZ) [left] and knockout (KO)
mice [right].
Figure 2 PAK1 in mouse endothelial cells. Western Blotting
showing PAK1 expression in mouse endothelial cell lysate.
Recombinant PAK1 protein was used as a positive control.
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http://www.biomedcentral.com/1471-2261/12/55cells [9]. On the basis of biochemical and structural fea-
tures, PAKs are classified into Group I, consisting of
PAK1-3, and Group II, consisting of PAK4-6 [10,11].
Among group I PAKs, PAK1 and -2 are widely
expressed, including in endothelial cells, whereas PAK3
is found largely in the brain. PAK substrates include
components of the mitogen-activated protein (MAP)
kinase pathway, cytoskeletal proteins such as filamin and
Op18, regulators of cell survival, and the transcription
factor nuclear factor (NF) – κB.
Previous work from our lab showed that in endothelial
cells, application of fluid shear stress activates PAK,
which subsequently controls junctional integrity and
vascular permeability [12–14]. Moreover, PAK is a crit-
ical modulator of several inflammatory pathways, includ-
ing NF-κB and JNK, such that PAK activity is required
for flow-dependent activation of these pathways and in-
duction of downstream genes. Furthermore, PAK activa-
tion in mouse arteries was observed specifically in
atherosclerosis-prone sites and correlated with inflam-
matory gene expression, including vascular cell adhesion
molecule-1 (VCAM-1). PAK inhibitors reduced NF-κB
Figure 3 Inflammatory markers FN and VCAM-1 in the lesser and greater curvature of PAK HZ and PAK KO mice. Fibronectin (FN) [left
panel] and VCAM-1 [right panel] were stained and imaged at 40X magnification in the lesser and greater curvatures of the PAK heterozygote (HZ)
and knockout (KO) mice [Panels top to bottom]. Each section was imaged at 5 different locations within a curvature zone to cover the entire
length of the greater (GC) and lesser curvature (LC), respectively. The bar graphs below each panel show the integrated density between the two
strains in the region of the greater and lesser curvatures. Sample size was n = 6 for PAK HZ and n = 7 for PAK KO. “*” represents significance <0.05
as analyzed by independent Student t-test.
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shear stress in vitro, and reduced vascular permeability
in vivo, indicating its functional significance in these
processes.
Remodeling of the subendothelial extracellular matrix
(ECM) appears to be an important component of ath-
erosclerotic progression [15]. Fibronectin localizes to the
subendothelial ECM selectively in atherosclerosis-prone
regions in vivo. In vitro, ECs on basement membrane
proteins show reduced inflammatory activation in re-
sponse to flow and other stimuli. By contrast, cells on
fibronectin, an ECM protein associated with remodeling,
injury and inflammation, respond strongly to the same
stimuli. PAK showed enhanced activation by flow, oxi-
dized LDL and MCP-1 in cells on fibronectin compared
to basement membrane proteins, and this differentialactivation of PAK mediates the ECM-specific activation
of NF-κB and JNK [13,14]. These effects form part of a
positive feedback loop in which inflammatory pathways
promote fibronectin gene expression and matrix assem-
bly, which subsequently enhances inflammation. Genetic
studies in mice and humans support a causal role for
ECM remodeling in atherosclerosis [16–18].
Previous studies of PAK in these processes were based
on the use of PAK inhibitors that are isoform nonspecific
and may have other non-specific effects. Therefore, to fur-
ther define the role of PAK in the biomechanical initiation
of the atherosclerotic cascade, we examined inflammatory
activation of the endothelium at atherosclerosis-prone
sites in PAK-1 knockout mice. These studies suggest
that PAK1 plays a significant role in initiation of
atherosclerosis.
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Cell culture
8-10 week old C57BL/6J mice were sacrificed, pressure
perfused, and the thoracic aortas were isolated. The
aorta was cut in 1 mm segments, which were placed on
a bed of matrigel with enriched EBM-2 media (see
below). Cells grow and migrate out into the matrigel bed
over 3-6 days. On day 7, the tissue was removed and
cells grown for an additional 3-6 days when they covered
the bottom of the well. Cells were released from the gel
with dispase, which was diluted in 3 cc of DMEM media
(with D-valine) containing 15% heat inactivated FBS
(“isolation medium”). Cells were isolated by low speed
centrifugation and plated on 0.25% gelatin coated dishes
in this medium to inhibit fibroblast growth. After day 7,
cells were switched to EBM-2 media containing 10%
FBS, 1% bovine brain extract, 60 μg/mL heparin (Sigma),
10 U/ml penicillin, and 10 μg/ml streptomycin and
Growth factor kit from Lorna Biosciences (growth
medium). Endothelial cell identity was tested by LDL
uptake. Cell lysates were run on a 10% SDS-PAGE
gel and probed for total PAK1-C19 antibody (recog-
nizes both PAK1 and 2) at 1:1000 primary antibody
dilution.Animals
PAK-/- C57Bl/6J mice were originally generated as
described in Clapp et al., 2009. Wild type C57Bl/6J mice
were purchased from Jackson Laboratories (Bar Harbour,
Maine). We used male 10-12 weeks old PAK KO, PAKFigure 4 Mac2 and ICAM-1 staining in the lesser curvature arch of PA
left to right) in the lesser curvature of ApoE null mice (positive control), PA
demonstrated in the lower panel. N = 5 for PAK HZ and PAK KO mice.HZ, and wild type C57BL/6J mice for our study (n = 7
for PAK HZ and C57BL/6 and n= 6 for PAK KO). All
mice were housed in temperature-controlled chambers
and fed a normal chow diet. The Laboratory Animal
Care and Use Committee of the Comparative Medicine
Department at University of Virginia approved all animal
procedures used in this study.Immunohistochemistry
Animals were sacrificed and pressure-perfused with cold
4% paraformaldehyde in 1X phosphate-buffered saline.
The complete aortas were dissected, processed, and em-
bedded in paraffin blocks. 5 μm longitudinal sections of
the aorta were used for immunohistochemistry (IHC).
Following microwave antigen retrieval with antigen
unmasking solution (Vector Labs), sections were stained
for: intracellular adhesion molecule (ICAM-1) 15 μl/ml
(Santacruz Biotechnology); vascular endothelial cell
adhesion molecule (VCAM-1) 5 μl/ml (Santacruz
Biotechnology); fibronectin (FN) 2.5 μl/ml (Sigma),
phospho-S536 p65 1:50 (Abcam); phospho-AKT 1:200
(Abcam); MAC2 1:10,000 (CedarLane Laboratories); and
phosphoS552-RelB 1:50 (Abcam). Sections were incu-
bated overnight at 4°C and visualized with Vectastain
Elite Kit (Vector Labs) with diaminobenzidine (DAB;
Deko Corp). Sections were counterstained with
Hematoxylin and exposed to 1 min of Bluing solution
for ICAM-1, VCAM-1, FN, p-AKT, MAC2, and p- RelB
and with Fast Green for p-p65. Positive (ApoE -/- mice
fed with a high fat diet) and negative controls validatedK HZ and PAK KO mice. The top panel shows Mac2 staining (from
K HZ, and PAK KO mice. In a similar representation, ICAM-1 staining is
Figure 5 Nuclear Factor (NF) – κB staining. DAB staining and image analysis reflecting p-p65 endothelial staining (left panel) and p-RelB
staining (right panel) in PAK HZ and PAK KO mice. Each protein staining is seen in the lesser curvature (LC) and greater curvature (GC) between
the two strains. ‘*’ indicates significance p< 0.05 between the two strains of mice. N = 6 in PAK HZ and n= 7 for PAK KO mice.
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(data not shown).
Imaging and analyses
Images were acquired using the 10X and 40X objectives
on an Olympus BX51 microscope equipped with an
Olympus DP70 digital camera using the ImagePro Plus
7.0 software program in the Academic Computing
Health Sciences Center at the University of Virginia. 7-8
images were acquired each for the greater and lesser
curvature per animal. Image J software was used to
quantify the intensity of endothelial staining between
strains in lesser curvature (atheroprone) and in greater
curvature (atheroprotective).
Staining was then quantified using an automated pro-
cedure. We first determined that the intima (from the
endothelium to the first lamina) was consistently 90
pixels wide. We next manually determined the threshold
intensity that corresponds to the minimal detectable
intensity in that region that excluded non-specific stain-
ing. To achieve consistency, the thresholds for each ofthe images (4-6 images per sample) were averaged and
the averaged threshold was used for each animal. This
correlation of constant area and averaged threshold
gave us integrated density (product of the area and
mean gray value that reflected each pixel staining).
Analysis was carried out with consistent area selection
across all markers, sections and strains. The selected
areas and thresholds are illustrated in Figure 1. This
procedure gave us consistent intensity data between
samples.
Results
Western blotting of lysate from isolated primary mouse
endothelial cells (ECs) with an isoform-specific antibody
showed PAK1 expression in these cells (Figure 2). We
therefore investigated its role in the inflammatory activa-
tion of the endothelium in WT and PAK1-/- mice. We
compared the lesser (inner) curvature of the aortic arch,
a site of flow disturbance, to the atherosclerosis-resistant
greater (outer) curvature where flow is laminar. We
examined arteries from 10-12 week old PAK KO, PAK
Figure 6 Akt activation. A) DAB staining revealed p-AKT staining in the lesser curvature (LC) of PAK HZ (Left panel) and PAK KO (Right panel). B)
Intensity analysis of DAB staining between PAK HZ and KO knockout (KO) mice. N = 5 for each strain.
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proteins that have been implicated in atherosclerosis or
flow signaling. The expression of the selected markers
was comparable between PAK HZ and C57BL/6 (data
not shown), thus, only the PAK HZ mice were used for
detailed comparison with the PAK1 KO mice.
We first stained for fibronectin (FN) as a marker for
matrix remodeling. FN localized specifically to the lesser
curvature as expected, but was strongly decreased in
PAK1 KO mice (Figure 3 left panel). We also examined
expression of the leukocyte adhesion receptors VCAM-1
and ICAM-1 as markers for immune activation of the
endothelium, and Mac2 to identify infiltrating mono-
cytes or macrophages. VCAM-1, which also specifically
localized to the lesser curvature relative to the greater
curvature, was decreased in the PAK KO compared toPAK HZ mice (Figure 3 right panel). Neither ICAM-1
(Figure 4 lower panel) nor Mac2 (Figure 4 top panel)
were detected in any of the mice. These results are
consistent with the age of the mice (10-12 weeks), since
inflammation is low in young C57Bl/6J mice fed on a
chow diet, though it increases with age (unpublished
data).
To detect activation of a critical pro-inflammatory sig-
naling pathway, we assayed activation of classical NF-κB
by staining for the RelA (p65) subunit phosphorylated
on an activating site, S536 (p-p65), which was previously
shown to be stimulated by fluid shear stress [19]. Stain-
ing localized specifically to the lesser curvature, as
expected, and was significantly decreased in PAK1-/-
vessels (Figure 5). Interestingly, staining for the alterna-
tive NF-κB subunit RelB with an antibody against an
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elevated in the lesser relative to the greater curvature,
was much higher in PAK1-/- mice than heterozygotes
(Figure 5). Staining for p-AKT did not reveal any differ-
ence between the two strains (Figure 6). However, the
phosphorylation was different between the lesser and
greater curvatures within the respective strains.
Discussion
In vitro studies identified a critical role for PAK family
kinases in the inflammatory activation of endothelial
cells by fluid shear stress but in vivo evidence is minimal
and the isoforms involved were not identified. The
current study was designed to explore the in vivo im-
portance of PAK in this process, focusing on PAK1. Our
results showed that expression or activation of FN,
VCAM-1, and classical NF-κB (RelA) were reduced in
aortas from PAK1-null mice. Decreased inflammatory
activation in PAK1-null mice fits well with in vitro find-
ings from our laboratory that PAK promotes inflamma-
tion in response to fluid shear stress [12–14]. These data
also highlight the importance of the PAK1 isoform in
these pathways. By contrast, PAK1 did not detectably
affect p-AKT, consistent with Akt’s role as a direct medi-
ator of flow signaling rather than an inflammatory medi-
ator. Levels of Mac-1 and ICAM-1 were very low,
consistent with the young age of the mice and the low
level of inflammation at this stage.
Interestingly, RelB, a component of the alternative
NF- κB pathway, was also activated in the lesser curva-
ture of the arch, but its activation greatly increased in
the absence of PAK1 expression. RelB-/- mice exhibit
multi-organ inflammation, suggesting that this subunit is
mainly immune-suppressive [20]. If it performs a similar
function in the endothelium, then elevated RelB activity
in PAK1-/- aortas is consistent with reduced inflamma-
tion in these mice. However, RelB has not been studied
in endothelial cells, thus, its functional role remains to
be investigated.
Importantly, WT C57Bl6 mice do not develop athero-
sclerosis in the absence of other stimuli such as
hypercholesterolemia [6]. Indeed, monocyte/macrophage
accumulation was nearly undetectable. Thus, the mild
inflammatory activation seen in this region is most likely
biomechanical. These results therefore suggest that
PAK1 plays a significant pro-inflammatory role in an
atherosclerosis-prone arterial region subject to disturbed
flow.
Conclusions
In conclusion, these results demonstrate a role for PAK1
in promoting inflammation at sites of disturbed flow
in vivo. This effect may be exerted via NF-κB activation,
gene expression and fibronectin deposition. Furtherstudies in hypercholesterolemic ApoE null or LDLR null
mice are required to determine whether these early
changes will translate into reduced atherosclerosis.
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